Historical record - last NADAC effective date: 12/21/2016
Product Information
METFORMIN HCL 1,000 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0283 per EA under NDC 67877022101. Its NADAC has been published 163 times since Nov 28, 2013.
FDA first approved this application on Nov 1, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877022101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
12/21/2016
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091184FDA Approved
11/1/2010
TE Code
AB
On Market Since
1/31/2011
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL 1,000 MG TABLET has been published 163 times since Nov 28, 2013, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0283 per EA |
|---|---|
| All-time high | $0.0392 (Feb 12, 2014) |
| All-time low | $0.0271 (Nov 23, 2016) |
| Median price | $0.0303 |
| Average price | $0.0309 |
| Largest weekly change | +18.4% (Jan 22, 2014) |
| Weeks tracked | 163 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-16.3%
Last surveyed Jan 4, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 16 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METFORMIN HCL 1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL 1,000 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0283 per EA (NDC 67877022101), effective Jan 4, 2017.
How has the price of METFORMIN HCL 1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL 1,000 MG TABLET has declined 16.3%. It has been tracked across 163 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL 1,000 MG TABLET?
Since Nov 28, 2013, the NADAC for METFORMIN HCL 1,000 MG TABLET has ranged from a low of $0.0271 (Nov 23, 2016) to a high of $0.0392 (Feb 12, 2014), with a median of $0.0303 per EA.
Are there cheaper alternatives to METFORMIN HCL 1,000 MG TABLET?
Yes. 16 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 1,000 MG TABLET, is $0.0231 per EA — about 18% below METFORMIN HCL 1,000 MG TABLET.
Who manufactures METFORMIN HCL 1,000 MG TABLET?
METFORMIN HCL 1,000 MG TABLET (NDC 67877022101) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.